Works matching DE "MULTIPLE myeloma"
Results: 5000
NK Cell Immaturity and NKp30 Expression Positively Correlate with Clinical Outcome in Multiple Myeloma Patients from the IFM2009 Clinical Trial.
- Published in:
- European Journal of Immunology, 2025, v. 55, n. 2, p. 1, doi. 10.1002/eji.202451191
- By:
- Publication type:
- Article
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice Experiment: Value of Innovative Multiple Myeloma Treatments: S. Syeed et al.
- Published in:
- PharmacoEconomics, 2025, v. 43, n. 4, p. 403, doi. 10.1007/s40273-024-01459-8
- By:
- Publication type:
- Article
CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 5, p. 1791, doi. 10.1007/s00259-024-07036-7
- By:
- Publication type:
- Article
Remineralization Rate of Lytic Lesions of the Spine in Multiple Myeloma Patients Undergoing Radiation Therapy.
- Published in:
- Global Spine Journal, 2025, v. 15, n. 3, p. 1712, doi. 10.1177/21925682241260651
- By:
- Publication type:
- Article
Medication‐related osteonecrosis of the jaw in an older patient with multiple myeloma.
- Published in:
- Gerodontology, 2025, v. 42, n. 1, p. 119, doi. 10.1111/ger.12758
- By:
- Publication type:
- Article
Cancer statistics for African American and Black people, 2025.
- Published in:
- CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 2, p. 111, doi. 10.3322/caac.21874
- By:
- Publication type:
- Article
Practical insights into bispecific antibody therapy in multiple myeloma.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 12, p. 1209, doi. 10.1080/14737140.2024.2445145
- By:
- Publication type:
- Article
How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 6, p. 335, doi. 10.1080/14737140.2024.2344650
- By:
- Publication type:
- Article
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 6, p. 379, doi. 10.1080/14737140.2024.2344647
- By:
- Publication type:
- Article
Targeting GPRC5D in multiple myeloma.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 5, p. 229, doi. 10.1080/14737140.2024.2343114
- By:
- Publication type:
- Article
Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First‐Line Treatment.
- Published in:
- Scandinavian Journal of Medicine & Science in Sports (Wiley-Blackwell), 2025, v. 35, n. 2, p. 1, doi. 10.1111/sms.70020
- By:
- Publication type:
- Article
T‐cell‐based immunotherapies for human immunodeficiency virus patient with relapsed/refractory multiple myeloma: A success story from our clinic.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 3, p. 988, doi. 10.1111/bjh.20002
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population‐based screening study.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 3, p. 899, doi. 10.1111/bjh.19957
- By:
- Publication type:
- Article
Dutcher bodies and Russell bodies in a case of t(11;14) multiple myeloma.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 3, p. 810, doi. 10.1111/bjh.19890
- By:
- Publication type:
- Article
Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 2, p. 763, doi. 10.1111/bjh.19937
- By:
- Publication type:
- Article
Autologous stem cell transplantation for multiple myeloma patients whose myeloma‐defining event was SLiM.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 2, p. 607, doi. 10.1111/bjh.19936
- By:
- Publication type:
- Article
CD71<sup>+</sup> erythroid cells promote multiple myeloma progression and impair anti‐bacterial immune response.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 2, p. 478, doi. 10.1111/bjh.19914
- By:
- Publication type:
- Article
EXPRESSIONOF CONCERN: HSP70 Inhibition Reverses Cell Adhesion Mediated and Acquired Drug Resistance in Multiple Myeloma.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 1, p. 399, doi. 10.1111/bjh.19955
- Publication type:
- Article
M‐protein‐related necrobiotic granuloma in a multiple myeloma patient treated with daratumumab, lenalidomide and dexamethasone.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 1, p. 16, doi. 10.1111/bjh.19887
- By:
- Publication type:
- Article
Another side of IgA neoplastic plasma cells.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 1, p. 11, doi. 10.1111/bjh.19867
- By:
- Publication type:
- Article
Evaluating early intervention in smoldering myeloma clinical trials: a systematic review.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae219
- By:
- Publication type:
- Article
Anaplastic Multiple Myeloma- a Morphological Challenge – A Case Series.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Identifying Myeloma Patients at Risk of Lenalidomide or Pomalidomide Resistance at Relapse: A New Opportunity.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2021, v. 42, n. 2, p. 180, doi. 10.1055/s-0041-1730090
- By:
- Publication type:
- Article
Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti‐CD38 Monoclonal Antibodies: A Systematic Review.
- Published in:
- Cancer Medicine, 2025, v. 14, n. 5, p. 1, doi. 10.1002/cam4.70585
- By:
- Publication type:
- Article
Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye.
- Published in:
- Diagnostics (2075-4418), 2025, v. 15, n. 5, p. 633, doi. 10.3390/diagnostics15050633
- By:
- Publication type:
- Article
Novel Approach to Rule-Out Unnecessary Urine Bence Jones Protein Testing: A Serum Free Light Chain Algorithm.
- Published in:
- Diagnostics (2075-4418), 2025, v. 15, n. 5, p. 525, doi. 10.3390/diagnostics15050525
- By:
- Publication type:
- Article
Multiparameter flow cytometric and transcriptional analyis of CD20 positive T-cells in bone marrow in patients of multiple myeloma and monoclonal gammopathy of undetermined significance.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1464940
- By:
- Publication type:
- Article
Current Treatment Strategies for Multiple Myeloma at First Relapse.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1655, doi. 10.3390/jcm14051655
- By:
- Publication type:
- Article
Unnecessary serum protein electrophoresis test requests in the follow-up of multiple myeloma patients can be prevented.
- Published in:
- International Journal of Medical Biochemistry, 2025, v. 8, n. 2, p. 125, doi. 10.14744/ijmb.2025.84748
- By:
- Publication type:
- Article
Solitary Plasmacytoma of Mandible Transforming to Multiple Myeloma? - A Rare Case Report.
- Published in:
- Oral & Maxillofacial Pathology Journal, 2024, v. 15, n. 2, p. 292
- By:
- Publication type:
- Article
Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma.
- Published in:
- Journal of Blood Medicine, 2025, v. 16, p. 7, doi. 10.2147/JBM.S489627
- By:
- Publication type:
- Article
Using QIP-MS to Guide the Timing of MRD Testing in Patients With Multiple Myeloma: A Budget Impact Analysis From the French Payer Perspective.
- Published in:
- ClinicoEconomics & Outcomes Research, 2025, v. 17, p. 107, doi. 10.2147/CEOR.S498848
- By:
- Publication type:
- Article
A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01226-8
- By:
- Publication type:
- Article
Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 3, p. e250802, doi. 10.1001/jamanetworkopen.2025.0802
- By:
- Publication type:
- Article
Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1529678
- By:
- Publication type:
- Article
Treatment patterns of patients with triple-class exposed refractory/relapsed multiple myeloma in Poland -- preliminary results of multicentre observational POMOST study.
- Published in:
- Acta Haematologica Polonica, 2025, v. 56, n. 1, p. 48, doi. 10.5603/ahp.103294
- By:
- Publication type:
- Article
Bispecific antibodies in multiple myeloma.
- Published in:
- Acta Haematologica Polonica, 2025, v. 56, n. 1, p. 39, doi. 10.5603/ahp.104091
- By:
- Publication type:
- Article
Profilin 1 induces drug resistance by downregulating CD138 expression via autophagy in multiple myeloma.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02036-x
- By:
- Publication type:
- Article
Comprehensive Analysis Identifies Hsa_circ_0058191 as a Potential Drug Resistance Target in Multiple Myeloma.
- Published in:
- OncoTargets & Therapy, 2025, v. 18, p. 225, doi. 10.2147/OTT.S505074
- By:
- Publication type:
- Article
Bibliometric and Bioinformatics Analysis of Renal Impairment in Multiple Myeloma: Trends and Research Hotspots, and Associated Genetic Pathways (2000-2023).
- Published in:
- Journal of Multidisciplinary Healthcare, 2025, v. 18, p. 1147, doi. 10.2147/JMDH.S501551
- By:
- Publication type:
- Article
Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy.
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 357, doi. 10.2147/CMAR.S510408
- By:
- Publication type:
- Article
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency.
- Published in:
- Cost Effectiveness & Resource Allocation, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12962-024-00600-w
- By:
- Publication type:
- Article
The unusual suspect: tadpole plasma cells.
- Published in:
- Annales de Biologie Clinique, 2025, v. 83, n. 1, p. 103, doi. 10.1684/abc.2025.1950
- By:
- Publication type:
- Article
CancerHubs: a systematic data mining and elaboration approach for identifying novel cancer-related protein interaction hubs.
- Published in:
- Briefings in Bioinformatics, 2025, v. 26, n. 1, p. 1, doi. 10.1093/bib/bbae635
- By:
- Publication type:
- Article
Neurological Outcomes and the Need for Retreatments Among Multiple Myeloma Patients With High-Grade Spinal Cord Compression: Radiotherapy vs Surgery.
- Published in:
- Global Spine Journal, 2025, v. 15, n. 2, p. 341, doi. 10.1177/21925682231188816
- By:
- Publication type:
- Article
Radiotherapy as a primary treatment modality for a young man with a primary urethral plasmacytoma: case report and literature review.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1528536
- By:
- Publication type:
- Article
Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy.
- Published in:
- Microbiome, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40168-025-02045-6
- By:
- Publication type:
- Article
Targeting GPRC5D With Talquetamab: A New Frontier in Bispecific Antibody Therapy for Relapsed/Refractory Multiple Myeloma.
- Published in:
- Annals of Pharmacotherapy, 2025, v. 59, n. 4, p. 350, doi. 10.1177/10600280241271192
- By:
- Publication type:
- Article
A novel mechanism in regulating drug sensitivity, growth, and apoptosis of bortezomib-resistant multiple myeloma cells: the USP4/KLF2/HMGA2 cascade.
- Published in:
- Journal of Orthopaedic Surgery & Research, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13018-025-05537-1
- By:
- Publication type:
- Article
The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1479164
- By:
- Publication type:
- Article